Search by Drug Name or NDC
NDC 72266-0249-10 POLYMYXIN B 500000 [USP'U]/1 Details
POLYMYXIN B 500000 [USP'U]/1
POLYMYXIN B is a INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by FOSUN PHARMA USA INC. The primary component is POLYMYXIN B SULFATE.
Product Information
| NDC | 72266-0249 |
|---|---|
| Product ID | 72266-249_fd663b0e-4789-7a45-e053-6294a90a8d11 |
| Associated GPIs | |
| GCN Sequence Number | 009354 |
| GCN Sequence Number Description | polymyxin B sulfate VIAL 500K UNIT INJECTION |
| HIC3 | W1N |
| HIC3 Description | POLYMYXIN ANTIBIOTICS AND DERIVATIVES |
| GCN | 41320 |
| HICL Sequence Number | 004049 |
| HICL Sequence Number Description | POLYMYXIN B SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | POLYMYXIN B |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | POLYMYXIN B SULFATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC |
| Active Ingredient Strength | 500000 |
| Active Ingredient Units | [USP'U]/1 |
| Substance Name | POLYMYXIN B SULFATE |
| Labeler Name | FOSUN PHARMA USA INC |
| Pharmaceutical Class | Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207322 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72266-0249-10 (72266024910)
| NDC Package Code | 72266-249-10 |
|---|---|
| Billing NDC | 72266024910 |
| Package | 10 VIAL in 1 CARTON (72266-249-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (72266-249-01) |
| Marketing Start Date | 2016-06-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |